Article
XLA-MTS: a distinct clinical genetic entity characterized by immunodeficiency and neurodevelopmental delay.
Orphanet journal of rare diseases - 25 Jun 2026
Ventura Ignacio, Revert-Ros Francisco, Revert Fernando, Marín-Paya Juan Carlos, Ruíz-Pérez Natalia, Prieto-Ruiz Jesús Ángel, Hernández-Andreu José Miguel
Abstract excerpt
BACKGROUND: Mohr-Tranebjærg syndrome (MTS) is a rare X-linked recessive neurodegenerative disorder, typically presenting with progressive sensorineural hearing loss in early childhood, followed by neurological deterioration, dystonia, ataxia, and visual impairment. OBJECTIVE: This study aimed to conduct a comprehensive clinical, genetic, and phenotypic review of MTS, with particular emphasis on mutations in the...
Read the complete abstract on PubMedTopics
- Humans
- Genetic Diseases, X-Linked
- Agammaglobulinaemia Tyrosine Kinase
- Hearing Loss, Sensorineural
- Mutation
